Logo image
New search Researchers Research units
Sign in
The use of stimulant medication to treat neurocognitive deficits in patients with pediatric cancer, traumatic brain injury, and sickle cell disease: a review
Journal article   Peer reviewed

The use of stimulant medication to treat neurocognitive deficits in patients with pediatric cancer, traumatic brain injury, and sickle cell disease: a review

Elizabeth Nicholls, Aimee K Hildenbrand, Richa Aggarwal, Lauren McCarthy and Brian Daly
Postgraduate medicine, v 124(5), pp 78-90
Sep 2012
PMID: 23095428

Abstract

Anemia, Sickle Cell - complications Attention - drug effects Brain Injuries - complications Central Nervous System Stimulants - therapeutic use Child Cognition Disorders - drug therapy Cognition Disorders - etiology Executive Function - drug effects Humans Learning - drug effects Neoplasms - complications Treatment Outcome

Metrics

3 Record Views
12 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Pediatrics
Logo image